Retrieving oocytes from small non-stimulated follicles in polycystic ovary syndrome (PCOS): In vitro maturation (IVM) is not indicated in the new GnRH antagonist era

Fertility and Sterility

Volumn 98, Issue 2, 2012, Pages 290-293

  De Ziegler, Dominique ^a   Streuli, Isabelle ^a   Gayet, Vanessa ^a   Frydman, Nelly ^a,b   Bajouh, Osama ^a   Chapron, Charles ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

ART; assisted reproductive treatments; In vitro maturation; IVM; PCOS; polycystic ovary syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN ANTAGONIST; PROGESTERONE;

ARTICLE; BIRTH RATE; CRYOPRESERVATION; ESTRADIOL BLOOD LEVEL; GERMINAL VESICLE; HUMAN; IN VITRO OOCYTE MATURATION; INFERTILITY THERAPY; LIVE BIRTH; LUTEINIZATION; NIDATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL;

ANIMALS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; IN VITRO OOCYTE MATURATION TECHNIQUES; INFERTILITY, FEMALE; OOCYTES; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME;

EID: 84864464674     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.06.043     Document Type: Article

References (52)

1. K.Y. Cha, J.J. Koo, J.J. Ko, D.H. Choi, S.Y. Han, and T.K. Yoon Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program Fertil Steril 55 1991 109 113
2. T.J. Child, A.K. Abdul-Jalil, B. Gulekli, and S.L. Tan In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome Fertil Steril 76 2001 936 942
3. T.J. Child, S.J. Phillips, A.K. Abdul-Jalil, B. Gulekli, and S.L. Tan A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries Obstet Gynecol 100 2002 665 670
4. J. de Mouzon, V. Goossens, and S. Bhattacharya Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE Hum Reprod 27 2012 954 966
5. T.D. Vause, A.P. Cheung, and S. Sierra Ovulation induction in polycystic ovary syndrome J Obstet Gynaecol Can 32 2010 495 502
6. B.C. Fauser, and A.M. Van Heusden Manipulation of human ovarian function: physiological concepts and clinical consequences Endocr Rev 18 1997 71 106
7. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
8. D. Dewailly, H. Gronier, and E. Poncelet Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries Hum Reprod 26 2011 3123 3129
9. M.A. Damario, L. Barmat, H.C. Liu, O.K. Davis, and Z. Rosenwaks Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients Hum Reprod 12 1997 2359 2365
10. J.A. Garcia-Velasco, V. Isaza, G. Quea, and A. Pellicer Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing? Fertil Steril 85 2006 547 554
11. A. Kahnberg, A. Enskog, M. Brannstrom, K. Lundin, and C. Bergh Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization Acta Obstet Gynecol Scand 88 2009 1373 1381
12. M. Aboulghar Treatment of ovarian hyperstimulation syndrome Semin Reprod Med 28 2010 532 539
13. T.H. Lee, C.H. Liu, and C.C. Huang Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum Reprod 23 2008 160 167
14. A.P. Yates, O. Rustamov, and S.A. Roberts Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Hum Reprod 26 2011 2353 2362
15. A. Trounson, C. Wood, and A. Kausche In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients Fertil Steril 62 1994 353 362
16. A. Le Du, I.J. Kadoch, and N. Bourcigaux In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience Hum Reprod 20 2005 420 424
17. R.C. Chian, B. Gulekli, W.M. Buckett, and S.L. Tan Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome N Engl J Med 341 1999 1624 1626
18. R.C. Chian, J.T. Chung, B.R. Downey, and S.L. Tan Maturational and developmental competence of immature oocytes retrieved from bovine ovaries at different phases of folliculogenesis Reprod Biomed Online 4 2002 127 132
19. J. Qiao, and H.L. Feng Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence Hum Reprod Update 17 2011 17 33
20. R. Fanchin, D. de Ziegler, J. Taieb, F. Olivennes, V.D. Castracane, and R. Frydman Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation Fertil Steril 73 2000 275 279
21. R. Orvieto, V. Yulzari-Roll, A. La Marca, J. Ashkenazi, and B. Fisch Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles Gynecol Endocrinol 21 2005 218 222
22. D. Cermik, B. Selam, and H.S. Taylor Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 238 243
23. H. Cakmak, and H.S. Taylor Implantation failure: molecular mechanisms and clinical treatment Hum Reprod Update 17 2011 242 253
24. E.M. Heijnen, M.J. Eijkemans, E.G. Hughes, J.S. Laven, N.S. Macklon, and B.C. Fauser A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome Hum Reprod Update 12 2006 13 21
25. J. Holte, T. Brodin, L. Berglund, N. Hadziosmanovic, M. Olovsson, and T. Bergh Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries Fertil Steril 96 2011 594 599
26. J.R. Mellembakken, S.L. Berga, M. Kilen, T.G. Tanbo, T. Abyholm, and P. Fedorcsak Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome Hum Reprod 26 2011 2499 2504
27. R. Koivunen, A. Pouta, and S. Franks Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study Hum Reprod 23 2008 2134 2139
28. S.B. Kjotrod, S.M. Carlsen, and P.E. Rasmussen Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study Hum Reprod 26 2011 2045 2053
29. D.R. Meldrum Preventing severe OHSS has many different facets Fertil Steril 97 2012 536 538
30. M. Aboulghar Agonist and antagonist coast Fertil Steril 97 2012 523 526
31. B.C. Fauser, D. de Jong, and F. Olivennes Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715
32. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization J Clin Endocrinol Metab 71 1990 918 922
33. Y. Gonen, M. Dirnfeld, S. Goldman, M. Koifman, and H. Abramovici The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF) J In Vitro Fert Embryo Transf 8 1991 254 259
34. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil Steril 56 1991 213 220
35. J. Itskovitz-Eldor, J. Levron, and S. Kol Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome Clin Obstet Gynecol 36 1993 701 710
36. M.A. Manzanares, J.L. Gomez-Palomares, E. Ricciarelli, and E.R. Hernandez Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels Fertil Steril 93 2010 1215 1219
37. M.A. Youssef, F. Van der Veen, and H.G. Al-Inany Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles Cochrane Database Syst Rev 2011 CD008046
38. P. Humaidan, H.E. Bredkjaer, and L. Bungum GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
39. D. Bodri, J.J. Guillen, A. Galindo, D. Mataro, A. Pujol, and O. Coll Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study Fertil Steril 91 2009 365 371
40. D. Bodri, J.J. Guillen, M. Trullenque, K. Schwenn, C. Esteve, and O. Coll Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study Fertil Steril 93 2010 2418 2420
41. G. Griesinger, S. von Otte, and A. Schroer Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study Hum Reprod 22 2007 1348 1352
42. G. Griesinger, L. Schultz, T. Bauer, A. Broessner, T. Frambach, and S. Kissler Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin- releasing hormone antagonist protocol in combination with a "freeze- all" strategy: a prospective multicentric study Fertil Steril 95 2011 2029-33.e1
43. P. Humaidan, L. Bungum, M. Bungum, and C. Yding Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod Biomed Online 13 2006 173 178
44. P. Humaidan, H. Ejdrup Bredkjaer, L.G. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
45. D. Griffin, C. Benadiva, N. Kummer, T. Budinetz, J. Nulsen, and L. Engmann Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders Fertil Steril 97 2012 1316 1320
46. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
47. L. Engmann, and C. Benadiva Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger Semin Reprod Med 28 2010 506 512
48. E. Cicinelli, D. de Ziegler, C. Bulletti, M.G. Matteo, L.M. Schonauer, and P. Galantino Direct transport of progesterone from vagina to uterus Obstet Gynecol 95 2000 403 406
49. E. Cicinelli, and D. de Ziegler Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus Hum Reprod Update 5 1999 365 372
50. E. Cicinelli, D. De Ziegler, S. Morgese, C. Bulletti, D. Luisi, and L.M. Schonauer "First uterine pass effect" is observed when estradiol is placed in the upper but not lower third of the vagina Fertil Steril 81 2004 1414 1416
51. L. Engmann, and C. Benadiva Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support Fertil Steril 97 2012 531 533
52. T. Imbar, S. Kol, F. Lossos, Y. Bdolah, A. Hurwitz, and R. Haimov-Kochman Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support Hum Reprod 27 2012 753 759